| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
RECEPTORS |
Departments of Molecular and Integrative Physiology (J.S., W.R.H., S.S., B.S.K.) and Chemistry (Y.R.H., J.A.K.), University of Illinois and University of Illinois College of Medicine, Urbana, Illinois 61801
Address all correspondence and requests for reprints to: Dr. Benita S. Katzenellenbogen, Department of Molecular and Integrative Physiology, 407 South Goodwin Avenue, 524 Burrill Hall, University of Illinois, Urbana, Illinois 61801-3704. E-mail: . katzenel{at}life.uiuc.edu
To develop compounds that are antagonists on ER
, but not ERß, we have added basic side-chains typically found in nonsteroidal antiestrogens to pyrazole compounds that bind with much higher affinity to ER
than to ERß. In this way we have developed basic side-chain pyrazoles (BSC-pyrazoles) that are high affinity, potent, selective antagonists on ER
. These BSC-pyrazoles are themselves inactive on ER
and ERß, and they antagonize E2 stimulation by ER
only. We investigated seven basic side-chain substituents on various alkyl-triaryl-substituted pyrazoles, and the most ER
-selective compound was methyl-piperidino-pyrazole (MPP). ER
-selective antagonism was observed on diverse reporter-promoter gene constructs containing estrogen response elements that are consensus, nonconsensus (pS2), or comprised of multiple half-estrogen response elements (NHERF/EBP50) and on genes in which ER works indirectly by tethering to other DNA-bound proteins (TGFß3). In contrast to these BSC-pyrazoles, the antiestrogens trans-hydroxytamoxifen, raloxifene, and ICI 182,780 suppress E2 activity via both ER
and ERß. The most effective BSC-pyrazole, MPP, fully antagonized E2 stimulation of pS2 mRNA in MCF-7 breast cancer cells, consistent with the fact that these cells contain almost exclusively ER
. These compounds should be useful in studying the biological functions of ER
and ERß and in selectively blocking responses that are mediated through ER
.
This article has been cited by other articles:
![]() |
S. Liu, C. Le May, W. P.S. Wong, R. D. Ward, D. J. Clegg, M. Marcelli, K. S. Korach, and F. Mauvais-Jarvis Importance of Extranuclear Estrogen Receptor-{alpha} and Membrane G Protein-Coupled Estrogen Receptor in Pancreatic Islet Survival Diabetes, October 1, 2009; 58(10): 2292 - 2302. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, K. Breen, and M. E Pepling Estrogen can signal through multiple pathways to regulate oocyte cyst breakdown and primordial follicle assembly in the neonatal mouse ovary J. Endocrinol., September 1, 2009; 202(3): 407 - 417. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Powell and W. Xu Intermolecular interactions identify ligand-selective activity of estrogen receptor {alpha}/{beta} dimers PNAS, December 2, 2008; 105(48): 19012 - 19017. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M Davis, J. Mao, B. Naz, J. A Kohl, and C. S Rosenfeld Comparative effects of estradiol, methyl-piperidino-pyrazole, raloxifene, and ICI 182 780 on gene expression in the murine uterus J. Mol. Endocrinol., October 1, 2008; 41(4): 205 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Alfinito, X. Chen, J. Atherton, S. Cosmi, and D. C. Deecher ICI 182,780 Penetrates Brain and Hypothalamic Tissue and Has Functional Effects in the Brain after Systemic Dosing Endocrinology, October 1, 2008; 149(10): 5219 - 5226. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-J. Chen, M.-T. Lee, H.-C. Yao, P.-W. Hsiao, F.-C. Ke, and J.-J. Hwang Crucial Role of Estrogen Receptor-{alpha} Interaction with Transcription Coregulators in Follicle-Stimulating Hormone and Transforming Growth Factor {beta}1 Up-Regulation of Steroidogenesis in Rat Ovarian Granulosa Cells Endocrinology, September 1, 2008; 149(9): 4658 - 4668. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bake, L. Ma, and F. Sohrabji Estrogen Receptor-{alpha} Overexpression Suppresses 17{beta}-Estradiol-Mediated Vascular Endothelial Growth Factor Expression and Activation of Survival Kinases Endocrinology, August 1, 2008; 149(8): 3881 - 3889. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mattsson, J. A Olsson, and B. Brunstrom Selective estrogen receptor {alpha} activation disrupts sex organ differentiation and induces expression of vitellogenin II and very low-density apolipoprotein II in Japanese quail embryos Reproduction, August 1, 2008; 136(2): 175 - 186. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Paulmurugan, A. Tamrazi, J. A. Katzenellenbogen, B. S. Katzenellenbogen, and S. S. Gambhir A Human Estrogen Receptor (ER){alpha} Mutation with Differential Responsiveness to Nonsteroidal Ligands: Novel Approaches for Studying Mechanism of ER Action Mol. Endocrinol., July 1, 2008; 22(7): 1552 - 1564. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Delbes, C. Duquenne, J. Szenker, J. Taccoen, R. Habert, and C. Levacher Developmental Changes in Testicular Sensitivity to Estrogens throughout Fetal and Neonatal Life Toxicol. Sci., September 1, 2007; 99(1): 234 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C Garrido-Gracia, A. Gordon, C. Bellido, R. Aguilar, I. Barranco, Y. Millan, J. M. de las Mulas, and J. E Sanchez-Criado The integrated action of oestrogen receptor isoforms and sites with progesterone receptor in the gonadotrope modulates LH secretion: evidence from tamoxifen-treated ovariectomized rats J. Endocrinol., April 1, 2007; 193(1): 107 - 119. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pinna, C. Bolego, P. Sanvito, V. Pelosi, R. Baetta, A. Corsini, R. M. Gaion, and A. Cignarella Raloxifene Elicits Combined Rapid Vasorelaxation and Long-Term Anti-Inflammatory Actions in Rat Aorta J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1444 - 1451. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gingerich and T. L. Krukoff Estrogen in the Paraventricular Nucleus Attenuates L-Glutamate-Induced Increases in Mean Arterial Pressure Through Estrogen Receptor {beta} and NO Hypertension, December 1, 2006; 48(6): 1130 - 1136. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bolego, E. Vegeto, C. Pinna, A. Maggi, and A. Cignarella Selective Agonists of Estrogen Receptor Isoforms: New Perspectives for Cardiovascular Disease Arterioscler Thromb Vasc Biol, October 1, 2006; 26(10): 2192 - 2199. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Lund, L. R. Hinds, and R. J. Handa The Androgen 5{alpha}-Dihydrotestosterone and Its Metabolite 5{alpha}-Androstan-3beta, 17beta-Diol Inhibit the Hypothalamo-Pituitary-Adrenal Response to Stress by Acting through Estrogen Receptor beta-Expressing Neurons in the Hypothalamus J. Neurosci., February 1, 2006; 26(5): 1448 - 1456. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Mishra, F. Z. Stanczyk, K. A. Burry, S. Oparil, B. S. Katzenellenbogen, M. L. Nealen, J. A. Katzenellenbogen, and R. K. Hermsmeyer Metabolite ligands of estrogen receptor-{beta} reduce primate coronary hyperreactivity Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H295 - H303. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Skretas and D. W. Wood Rapid Detection of Subtype-Selective Nuclear Hormone Receptor Binding with Bacterial Genetic Selection Appl. Envir. Microbiol., December 1, 2005; 71(12): 8995 - 8997. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. T. Ruiz-Cortes, S. Kimmins, L. Monaco, K. H. Burns, P. Sassone-Corsi, and B. D. Murphy Estrogen Mediates Phosphorylation of Histone H3 in Ovarian Follicle and Mammary Epithelial Tumor Cells via the Mitotic Kinase, Aurora B Mol. Endocrinol., December 1, 2005; 19(12): 2991 - 3000. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gingerich and T. L. Krukoff Estrogen Modulates Endothelial and Neuronal Nitric Oxide Synthase Expression via an Estrogen Receptor {beta}-Dependent Mechanism in Hypothalamic Slice Cultures Endocrinology, July 1, 2005; 146(7): 2933 - 2941. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Klinge, K. A. Blankenship, K. E. Risinger, S. Bhatnagar, E. L. Noisin, W. K. Sumanasekera, L. Zhao, D. M. Brey, and R. S. Keynton Resveratrol and Estradiol Rapidly Activate MAPK Signaling through Estrogen Receptors {alpha} and {beta} in Endothelial Cells J. Biol. Chem., March 4, 2005; 280(9): 7460 - 7468. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Kim, A. Tamrazi, K. E. Carlson, and J. A. Katzenellenbogen A Proteomic Microarray Approach for Exploring Ligand-initiated Nuclear Hormone Receptor Pharmacology, Receptor Selectivity, and Heterodimer Functionality Mol. Cell. Proteomics, March 1, 2005; 4(3): 267 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Lund, T. Rovis, W. C. J. Chung, and R. J. Handa Novel Actions of Estrogen Receptor-{beta} on Anxiety-Related Behaviors Endocrinology, February 1, 2005; 146(2): 797 - 807. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Chen, B. S. Katzenellenbogen, J. A. Katzenellenbogen, and H. Zhao Directed Evolution of Human Estrogen Receptor Variants with Significantly Enhanced Androgen Specificity and Affinity J. Biol. Chem., August 6, 2004; 279(32): 33855 - 33864. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Turgeon, D. P. McDonnell, K. A. Martin, and P. M. Wise Hormone Therapy: Physiological Complexity Belies Therapeutic Simplicity Science, May 28, 2004; 304(5675): 1269 - 1273. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Barchiesi, E. K. Jackson, B. Imthurn, J. Fingerle, D. G. Gillespie, and R. K. Dubey Differential Regulation of Estrogen Receptor Subtypes {alpha} and {beta} in Human Aortic Smooth Muscle Cells by Oligonucleotides and Estradiol J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2373 - 2381. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Heldring, M. Nilsson, B. Buehrer, E. Treuter, and J.-A. Gustafsson Identification of Tamoxifen-Induced Coregulator Interaction Surfaces within the Ligand-Binding Domain of Estrogen Receptors Mol. Cell. Biol., April 15, 2004; 24(8): 3445 - 3459. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Ramsey, K. E. Risinger, S. C. Jernigan, K. A. Mattingly, and C. M. Klinge Estrogen Receptor {beta} Isoforms Exhibit Differences in Ligand-Activated Transcriptional Activity in an Estrogen Response Element Sequence-Dependent Manner Endocrinology, January 1, 2004; 145(1): 149 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lassurguere, G. Livera, R. Habert, and B. Jegou Time- and Dose-Related Effects of Estradiol and Diethylstilbestrol on the Morphology and Function of the Fetal Rat Testis in Culture Toxicol. Sci., May 1, 2003; 73(1): 160 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sun, J. Baudry, J. A. Katzenellenbogen, and B. S. Katzenellenbogen Molecular Basis for the Subtype Discrimination of the Estrogen Receptor-{beta}-Selective Ligand, Diarylpropionitrile Mol. Endocrinol., February 1, 2003; 17(2): 247 - 258. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Clark, M. C. Kelton, and A. C. Whitney Chronic Administration of Anabolic Steroids Disrupts Pubertal Onset and Estrous Cyclicity in Rats Biol Reprod, February 1, 2003; 68(2): 465 - 471. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Harris, J. A. Katzenellenbogen, and B. S. Katzenellenbogen Characterization of the Biological Roles of the Estrogen Receptors, ER{alpha} and ER{beta}, in Estrogen Target Tissues in Vivo through the Use of an ER{alpha}-Selective Ligand Endocrinology, November 1, 2002; 143(11): 4172 - 4177. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |